RVMD – Revolution Medicines, Inc.
Revolution Medicines, Inc.RVMD
$36.76Name : Revolution Medicines, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $6,834,161,152.00
EPSttm : -3.58
Revolution Medicines, Inc.
$36.76
1.55%$0.56Float Short %
10.02
Margin Of Safety %
Put/Call OI Ratio
1.37
EPS Next Q Diff
0.03
EPS Last/This Y
-0.9
EPS This/Next Y
-0.23
Price
36.76
Target Price
72.33
Analyst Recom
1.08
Performance Q
-7.87
Relative Volume
0.84
Beta
1.09
Ticker: RVMD
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-21 | RVMD | 38.13 | 1.50 | 0.00 | 16597 |
| 2025-03-24 | RVMD | 39.31 | 3.74 | 0.00 | 12274 |
| 2025-03-25 | RVMD | 38.47 | 3.56 | 0.50 | 12400 |
| 2025-03-26 | RVMD | 37.69 | 3.56 | 0.75 | 12404 |
| 2025-03-27 | RVMD | 38.09 | 3.56 | 19.20 | 12409 |
| 2025-03-28 | RVMD | 37.33 | 3.43 | 999.99 | 12059 |
| 2025-03-31 | RVMD | 35.36 | 3.38 | 0.57 | 11920 |
| 2025-04-01 | RVMD | 33.43 | 3.36 | 0.11 | 11966 |
| 2025-04-02 | RVMD | 34.58 | 3.33 | 0.02 | 11993 |
| 2025-04-03 | RVMD | 32.89 | 3.29 | 0.54 | 12031 |
| 2025-04-04 | RVMD | 31.3 | 3.29 | 0.15 | 12165 |
| 2025-04-07 | RVMD | 31.4 | 3.20 | 0.13 | 12248 |
| 2025-04-08 | RVMD | 31.14 | 3.16 | 0.01 | 12286 |
| 2025-04-09 | RVMD | 35.1 | 2.52 | 0.00 | 12319 |
| 2025-04-10 | RVMD | 33.7 | 1.47 | 0.00 | 14840 |
| 2025-04-11 | RVMD | 35.74 | 1.47 | 0.33 | 14842 |
| 2025-04-14 | RVMD | 36.46 | 1.47 | 0.00 | 14865 |
| 2025-04-15 | RVMD | 36.3 | 1.47 | 0.00 | 14892 |
| 2025-04-16 | RVMD | 36.2 | 1.45 | 0.00 | 14984 |
| 2025-04-17 | RVMD | 36.8 | 1.37 | 0.07 | 15322 |
| 2025-04-18 | RVMD | 36.76 | 1.37 | 0.07 | 15322 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-21 | RVMD | 38.15 | -48.2 | -111.4 | -4.42 |
| 2025-03-24 | RVMD | 39.34 | -48.2 | -158.0 | -4.42 |
| 2025-03-25 | RVMD | 38.45 | -48.2 | -95.6 | -4.42 |
| 2025-03-26 | RVMD | 37.72 | -48.2 | -99.7 | -4.42 |
| 2025-03-27 | RVMD | 38.08 | -48.2 | -133.0 | -4.42 |
| 2025-03-28 | RVMD | 37.35 | -48.2 | -98.8 | -4.42 |
| 2025-03-31 | RVMD | 35.36 | -48.2 | -59.0 | -4.42 |
| 2025-04-01 | RVMD | 33.62 | -51.2 | -208.8 | -4.49 |
| 2025-04-02 | RVMD | 34.60 | -51.2 | -323.3 | -4.48 |
| 2025-04-03 | RVMD | 32.87 | -51.2 | -207.3 | -4.48 |
| 2025-04-04 | RVMD | 31.29 | -50.7 | -208.2 | -4.48 |
| 2025-04-07 | RVMD | 31.43 | -50.7 | -287.1 | -4.48 |
| 2025-04-08 | RVMD | 31.13 | -50.7 | -266.9 | -4.48 |
| 2025-04-09 | RVMD | 35.12 | -50.7 | -475.6 | -4.48 |
| 2025-04-10 | RVMD | 33.70 | -50.7 | -221.7 | -4.48 |
| 2025-04-11 | RVMD | 35.73 | -50.7 | -370.1 | -4.48 |
| 2025-04-14 | RVMD | 36.47 | -50.7 | -310.2 | -4.48 |
| 2025-04-15 | RVMD | 36.32 | -50.8 | -274.4 | -4.48 |
| 2025-04-16 | RVMD | 36.23 | -50.8 | -276.7 | -4.48 |
| 2025-04-17 | RVMD | 36.76 | -50.8 | -302.3 | -4.48 |
| 2025-04-18 | RVMD | 36.76 | -50.8 | -280.3 | -4.48 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-21 | RVMD | 4.43 | 15.42 | 9.79 |
| 2025-03-24 | RVMD | 4.42 | 15.42 | 9.79 |
| 2025-03-25 | RVMD | 4.42 | 15.42 | 9.80 |
| 2025-03-26 | RVMD | 4.42 | 15.42 | 10.30 |
| 2025-03-27 | RVMD | 4.42 | 15.42 | 10.30 |
| 2025-03-28 | RVMD | 4.42 | 15.42 | 10.30 |
| 2025-03-31 | RVMD | 4.42 | 15.39 | 10.30 |
| 2025-04-01 | RVMD | 4.42 | 15.39 | 10.30 |
| 2025-04-02 | RVMD | 4.42 | 15.39 | 10.30 |
| 2025-04-03 | RVMD | 4.42 | 15.39 | 10.30 |
| 2025-04-04 | RVMD | 4.46 | 15.39 | 10.30 |
| 2025-04-07 | RVMD | 4.46 | 15.39 | 10.30 |
| 2025-04-08 | RVMD | 4.46 | 15.39 | 10.30 |
| 2025-04-09 | RVMD | 4.46 | 15.39 | 10.30 |
| 2025-04-10 | RVMD | 4.46 | 15.39 | 10.02 |
| 2025-04-11 | RVMD | 4.49 | 15.39 | 10.02 |
| 2025-04-14 | RVMD | 4.49 | 15.39 | 10.02 |
| 2025-04-15 | RVMD | 4.49 | 15.39 | 10.02 |
| 2025-04-16 | RVMD | 4.92 | 15.39 | 10.02 |
| 2025-04-17 | RVMD | 4.99 | 15.39 | 10.02 |
| 2025-04-18 | RVMD | 4.99 | 15.39 | 10.02 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.12
Avg. EPS Est. Current Quarter
-1.06
Avg. EPS Est. Next Quarter
-1.09
Insider Transactions
4.99
Institutional Transactions
15.39
Beta
1.09
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
9
Growth Score
25
Sentiment Score
84
Actual DrawDown %
41.1
Max Drawdown 5-Year %
-73.3
Target Price
72.33
P/E
Forward P/E
PEG
P/S
P/B
3.02
P/Free Cash Flow
EPS
-3.57
Average EPS Est. Cur. Y
-4.48
EPS Next Y. (Est.)
-4.71
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.84
Return on Equity vs Sector %
-46.5
Return on Equity vs Industry %
-33.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.06
EBIT Estimation
-280.3
Revolution Medicines, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 534
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading